Literature DB >> 31733181

Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.

Duk-Hyun Kang1, Sung-Ji Park1, Seung-Ah Lee1, Sahmin Lee1, Dae-Hee Kim1, Hyung-Kwan Kim1, Sung-Cheol Yun1, Geu-Ru Hong1, Jong-Min Song1, Cheol-Hyun Chung1, Jae-Kwan Song1, Jae-Won Lee1, Seung-Woo Park1.   

Abstract

BACKGROUND: The timing and indications for surgical intervention in asymptomatic patients with severe aortic stenosis remain controversial.
METHODS: In a multicenter trial, we randomly assigned 145 asymptomatic patients with very severe aortic stenosis (defined as an aortic-valve area of ≤0.75 cm2 with either an aortic jet velocity of ≥4.5 m per second or a mean transaortic gradient of ≥50 mm Hg) to early surgery or to conservative care according to the recommendations of current guidelines. The primary end point was a composite of death during or within 30 days after surgery (often called operative mortality) or death from cardiovascular causes during the entire follow-up period. The major secondary end point was death from any cause during follow-up.
RESULTS: In the early-surgery group, 69 of 73 patients (95%) underwent surgery within 2 months after randomization, and there was no operative mortality. In an intention-to-treat analysis, a primary end-point event occurred in 1 patient in the early-surgery group (1%) and in 11 of 72 patients in the conservative-care group (15%) (hazard ratio, 0.09; 95% confidence interval [CI], 0.01 to 0.67; P = 0.003). Death from any cause occurred in 5 patients in the early-surgery group (7%) and in 15 patients in the conservative-care group (21%) (hazard ratio, 0.33; 95% CI, 0.12 to 0.90). In the conservative-care group, the cumulative incidence of sudden death was 4% at 4 years and 14% at 8 years.
CONCLUSIONS: Among asymptomatic patients with very severe aortic stenosis, the incidence of the composite of operative mortality or death from cardiovascular causes during the follow-up period was significantly lower among those who underwent early aortic-valve replacement surgery than among those who received conservative care. (Funded by the Korean Institute of Medicine; RECOVERY ClinicalTrials.gov number, NCT01161732.).
Copyright © 2019 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2019        PMID: 31733181     DOI: 10.1056/NEJMoa1912846

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

1.  Supraglottic Airway Use for Transfemoral-Transcatheter Aortic Valve Replacement.

Authors:  Shara S Azad; Frederick C Cobey; Lori Lyn Price; Roman Schumann; Alexander D Shapeton
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-05-15       Impact factor: 2.628

2.  The Early Bird Catches the Worm: Should Severe LVH Be an Indication for Early TAVR?

Authors:  Deepak L Bhatt; Anubodh S Varshney
Journal:  JACC Cardiovasc Interv       Date:  2020-06-08       Impact factor: 11.195

3.  Long-term outcomes of sutureless and rapid-deployment aortic valve replacement: a systematic review and meta-analysis.

Authors:  Michael L Williams; Campbell D Flynn; Andrew A Mamo; David H Tian; Utz Kappert; Manuel Wilbring; Thierry Folliguet; Antonio Fiore; Antonio Miceli; Augusto D'Onofrio; Giorgia Cibin; Gino Gerosa; Mattia Glauber; Theodor Fischlein; Francesco Pollari
Journal:  Ann Cardiothorac Surg       Date:  2020-07

Review 4.  Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement.

Authors:  Xu Yu Jin; Mario Petrou; Jiang Ting Hu; Ed D Nicol; John R Pepper
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

5.  Early aortic valve surgery reduces mortality.

Authors:  Karina Huynh
Journal:  Nat Rev Cardiol       Date:  2020-02       Impact factor: 32.419

6.  Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations.

Authors:  Mohammed Y Khanji; Fabrizio Ricci; Victor Galusko; Baskar Sekar; C Anwar A Chahal; Laura Ceriello; Sabina Gallina; Simon Kennon; Wael I Awad; Adrian Ionescu
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-07-21

7.  Asymptomatic patients with very severe aortic stenosis-operate or watch?

Authors:  Pradeep Narayan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-02-02

Review 8.  [ESC/EACTS guidelines 2021 on the management of valvular heart diseases : What are the most important innovations?]

Authors:  F S Nettersheim; S Baldus
Journal:  Herz       Date:  2021-10-05       Impact factor: 1.443

9.  Reverse remodelling after aortic valve replacement for chronic aortic regurgitation.

Authors:  Ayumi Koga-Ikuta; Satsuki Fukushima; Naonori Kawamoto; Tetsuya Saito; Yusuke Shimahara; Shin Yajima; Naoki Tadokoro; Takashi Kakuta; Toshihiro Fukui; Tomoyuki Fujita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28

Review 10.  Dissecting Calcific Aortic Valve Disease-The Role, Etiology, and Drivers of Valvular Fibrosis.

Authors:  Petra Büttner; Lukas Feistner; Philipp Lurz; Holger Thiele; Joshua D Hutcheson; Florian Schlotter
Journal:  Front Cardiovasc Med       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.